PATENT CLAIM ANALYSIS

Application Number: 15742087
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "139100"]

Abstract:
The present invention relates to Tau-binding antibodies and binding fragments thereof.

Claim (Index 24):
The isolated Tau-binding antibody or binding fragment thereof of  claim 21 , wherein said Tau-binding antibody or binding fragment thereof comprises:\n a light chain comprising SEQ ID NO: 14 or sequences at least 80% identical thereto, and/or a heavy chain comprising SEQ ID NO: 17 or 18.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15742070', '14654176', '13271118', '15257086', '14532531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7451684652914333
- 35 USC 102 Novelty (BERT): 0.6017484758138331
- Combined Prediction Score: 0.7308264663436732
- Mean Citation Score: 441.577828
- Max Citation Score: 534.597
- Similarity Product: 461.09823549807066

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test